Influence of Interferon alpha-2a Treatment on Monocyte Subsets in Patients with Uveitis
TURKISH JOURNAL OF IMMUNOLOGY, cilt.8, sa.2, ss.50-56, 2020 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 8 Sayı: 2
- Basım Tarihi: 2020
- Doi Numarası: 10.25002/tji.2020.1261
- Dergi Adı: TURKISH JOURNAL OF IMMUNOLOGY
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.50-56
- Anahtar Kelimeler: Monocyte, Behcet's disease, uveitis, interferon alpha, PD-1, ADALIMUMAB, ACTIVATION, EFFICACY, THERAPY, SAFETY, CELLS
- İstanbul Üniversitesi Adresli: Evet
Özet
Introduction: Interferon alpha is a type-I interferon molecule with antiviral and antineoplastic properties. Interferon a treatment is also used in the management of uveitis and believed to have immunomodulatory properties demonstrated by increased number of regulatory T cells. The aim of this study was to define the influence of interferon alpha-2a treatment on monocyte subsets in patients with uveitis.